fbpx
    • Multiple Myeloma News
    • Myeloma Crowd Newsroom
    • Nov 03, 2014

    New Drug May Help Erase Low Platelets Due To Bortezomib (Velcade). A News Segment Interview

BY LIZZY SMITH

In September, I was interviewed about my experience with taking the drug Bortezomib (Velcade). One of the side effects is low platelet counts, which I experienced early in my treatment. In fact, I needed several infusions of blood products, including platelets, prior to my transplant. Every time I got platelets, I felt like a new person. Now, according to the University of Utah, an existing drug may be approved for those of us with low platelets that could erase that side effect entirely. Hooray!

Here is a link to the interview, which will be shown across the country in news broadcasts throughout the month of November. Who knows, maybe you’ll catch it on a local news channel where you live.

Drug To Help Side Effects of Bortezomib

A little side note about this interview. I was actually battling a horrific stomach flu that day. I had to take many breaks because I thought I would pass out, and also to run to the restroom to throw up. It was one of the hardest things I’ve ever done. But I did it! I think I learned this trait during my stem cell transplants– pushing past pain and discomfort with a smile.

About Author

Lizzy Smith was diagnosed with myeloma in 2012 at age 44. Within days, she left her job, ended her marriage, moved, and entered treatment. "To the extent I'm able, I want to prove that despite life's biggest challenges, it is possible to survive and come out stronger than ever," she says.

MYELOMA CROWD RESEARCH INITIATIVE
$104,527 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal
AmazonSmile

Get Started Today.

Find a Clinical Trial that's Right for You

Go

Thanks to our site sponsors: